Selecta Biosciences’ Merger with Cartesian Therapeutics

Covington & Burling advised Selecta Biosciences, Inc. on the transaction, and Foley Hoag advised Cartesian Therapeutics.Selecta Biosciences (Nasdaq:SELB) (“Selecta”) announced its merger with Cartesian Therapeutics and concurrent $60.25…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now